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Abstract Endometriosis is a chronic disease affecting mainly
women of the reproductive age. Its most common manifesta-
tions include impaired fecundity, pelvic pain, and dyschezia.
Laparoscopic removal of endometriotic foci remains to be the
gold standard for the treatment of endometriosis. More effec-
tive techniques of endoscopic approach—among others, laser
application—are continually being developed. The aim of the
study was to evaluate the efficacy of laparoscopic treatment
with the use of CO2 laser ablation vs. electroablation with
regard to pain complaints in the affected patients. The study
included 48 women (aged 22–42) with varying degrees of
endometriosis of the lesser pelvis. The Numeric Rating Scale
(NRS) was used to evaluate pain intensity before the surgery
in all patients, followed by either laser ablation or
electroablation of the endometriotic foci. The results of the
laparoscopic treatment were monitored after 3 and 6 months
postoperatively. p value of 0.05 was considered to be statisti-
cally significant. Patients from both groups reported less in-
tensive pain before/during menstruation (dysmenorrhea)
6 months postoperatively, with more distinct tendency in the
electroablation group (p=0.004) as compared to the laser
ablation group (p=0.025). Despite the initial improvement
reported at the 3-month checkup (p=0.008), 6 months post-
operatively, a statistically significant increase in pain intensity
was noted in both groups (p=0.016 and p=0.032 for CO2
laser ablation and electroablation, respectively). Both surgical
methods seem to be effective only in the treatment of
endometriosis-related dysmenorrhea, whereas the intensity
of other pain complaints (dyspareunia, dysuria, dyschezia,
pelvic pain syndrome (PPS)) has remained on the same level.
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Introduction
Endometriosis is an estrogen-dependent chronic disease with
the incidence of 30–40% inwomenwith pain complaints of the
lesser pelvis [1, 2]. The disease is estimated to affect 10–15 %
of asymptomatic women of the reproductive age [3]. Endome-
triosis is connected with the presence of ectopic endometrial
cells within the organs of the lesser pelvis and with biochem-
ical, molecular, and hormonal changes which negatively affect
the homeostasis in a female body. Endometriotic women are
known to have elevated levels of macrophages [4], dendritic
cells [5], and peritoneal fluid NK cells as well as abnormal
levels of inflammatory mediators, i.e., interleukin-1 (IL-1), Il-6,
IL-8, substance P, and tumor necrosis factor (TNF). Distur-
bances in the functioning of the immune system lead to chronic
inflammatory processes [6] and are associated with the appear-
ance of the following symptoms of inflammation: dysmenor-
rhea, dysuria, and dyspareunia. The presence of the
abovementioned manifestations is connected with the patho-
genesis of endometriosis as well as the consequences of an
inflammation, namely intraperitoneal adhesions [7]. The foci of
ectopic endometrial cells may develop within the ovaries,
fallopian tubes, corpus uteri, Douglas pouch, vesicouterine
pouch, as well as outside the pelvis, for example on the surface
of colon, parietal peritoneum, and abdominal tissue. The most
common, nonspecific endometriosis-related complaints include
dysmenorrhea, dyspareunia, dysuria, dyschezia, and noncyclic
(not related to menstrual cycle) chronic pelvic pain. The pain
may be correlated with the advancement of the endometrial
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lesions, but only in grades III and IV cases, whereas grades I
and II have not been confirmed to be related [8, 9].
Endometriosis is clinically graded into four stages of ad-
vancement according to the revised American Society of
Reproductive Medicine classification. The Chapron classifi-
cation (2003) is an example of another system, which intro-
duced the deep infiltrating endometriosis (DIE) term as the
main cause of pain complaints, depending on the location
within the organs of the lesser pelvis [10]. Apart from DIE,
endometriosis can be staged into ovarian and peritoneal.
The consequences of the disease are a serious and complex
social issue, although it is often underestimated or ignored.
Endometriosis is a multifactorial disease [11] and extends
beyond a mere medical condition, resulting in impaired fe-
cundity, disturbed family relations, and leaves of absence from
work due to chronic pain complaints.
Laparoscopy remains to be the gold standard in the diag-
nosis and treatment of endometriosis [12]. Enucleation or
destruction of cysts, removal or destruction of the focal le-
sions, lysis of adhesions, and/or the nerve-sparing procedure
of selective laparoscopic uterine nerve ablations (LUNAs) of
the uterosacral ligaments belong the most common laparo-
scopic methods applied in the treatment of the disease. These
techniques aim to maximize the therapeutic effect and mini-
mize the side effects, i.e., damage to the healthy tissue. CO2
laser ablation seems to be the most beneficial of them all, as it
allows for a precise vaporization of endometriotic lesions with
good homeostasis and minimal damage to surrounding tissue.
The latter is especially important in the event of a removal of
the endometrial cysts within the ovary, as it allows preserva-
tion of the ovarian reservoir [13, 14].
The efficacy of laser ablation of endometrial implants to
reduce pain is estimated at almost 65 % [15]. However, there is
no consensus on the positive therapeutic effect of other classical
laparoscopic techniques such as electroablation [16]. Latest
research shows that laparoscopy with surgical management of
the focal lesions has a beneficial therapeutic effect and lowers
the possibility of recurrence of endometrial cysts and com-
plaints. It also increases the chances of conception [17].
Objectives
The aim of the study was to evaluate the therapeutic effect of
two laparoscopic techniques, electroablation of endometriosis
vs. CO2 laser ablation, to reduce a variety of pain complaints
in the affected individuals.
Material and methods
A laser is a device that emits electromagnetic radiation in
various ranges of wavelengths: visible light, ultraviolet, or
infrared radiation, by using stimulated emission. The name
is an acronym of the light amplification by stimulated emis-
sion of radiation.
Laser radiation is coherent, usually polarized, and the
beams have very small divergence. Narrow emission
linewidth, which corresponds to a high power in a selected,
narrow spectrum range, may be easily generated. The CO2
laser is a gas laser based on a gas mixture of carbon dioxide,
nitrogen, hydrogen, and helium. The main spectral lines are
within the wavelength of 9.4 and 10.6 μm, and the emitted
power reaches 100 kW at continuous and 1013 pulsed opera-
tion. The AcuPulse CO2 laser of 30–40 W (Lumenis, Israel),
connected to a laparoscope (Storz, Germany), and Aida soft-
ware (Storz, Germany) to archive data were used in the study.
A total of 48 patients with ovarian endometriosis and DIE,
grades I (n=0), II (n=4), III (n=37), and IV (n=7) according
to rARSM, prepared for laparoscopic removal of
endometriotic lesions at the Clinic of Gynecology and Oncol-
ogy, Kraków, between 2011 and 2012, were recruited for the
study. Exclusion criteria were the following: pregnancy, his-
tory of surgery within the abdominal cavity, history of pelvic
inflammatory disease, and prolonged use of oral contracep-
tives. Before the surgery, all patients filled a questionnaire on
pain complaints during the 3 months preceding the study.
Numerical Rating Scale (NRS) was used in the questionnaire,
with 0 for “no pain” and 10 for “unbearable pain,” to evaluate
the intensity of five types of pain during menstruation, urina-
tion, defecation, sexual intercourse, as well as noncyclic pel-
vic pain syndrome (PPS). The respondents were also asked to
submit information on their use of painkillers. Patients
deemed eligible for the study underwent a gynecological
examination and an ultrasound test with the use of
transvaginal probe, 2D/3D/4D 5–9 MHz, Voluson E6 (Gen-
eral Electrics, USA). All women underwent laparoscopic de-
struction of the endometriotic foci. The subjects were random-
ized into the laser ablation (n=15) and electroablation (n=33)
groups. At the 3- and 6-month checkup, the patients complet-
ed the pain questionnaire again. Additionally, changes in
painkiller use were also investigated. At the first visit, when
patients deemed eligible for the study were selected and all
control checkups, the subjects were examined with the use of
a transvaginal ultrasound to evaluate the presence of
Table 1 Patient characteristics: electroablation group
No. of patients (n=33) Mean Median Min. value Max. value
Age 30.91 30 23 42
BMI 21.67 21.61 17.65 27.92
Dysmenorrhea 6.03 7.00 0 10
Dyschezia 1.09 0.0 0 8
Dysuria 1.06 0.0 0 8
PPS 2.46 2.97 0 10
Dyspareunia 2.94 3.0 0 9
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endometrioid lesions. The tests were performed by the same
experienced and certified (ISUOG, PTG, IOTA) doctor,
Agnieszka Nocuń.
Statistical analyses
Student’s t test for matched pairs (for near-normally distributed
variables) and nonparametric Wilcoxon test (for no-normally
distributed variables) were used to evaluate changes in pain
intensity.McNemar’s test was used to analyze the percentage of
patients using antispasmodic drugs (e.g., No-Spa—drotaverine
hydrochloride) and nonsteroidal anti-inflammatory drugs
(NSAIDs) (the most commonly used). Student’s t test for
independent groups andMann-WhitneyU test for nonnormally
distributed variables were used for the comparison between
changes in pain intensity inpatients with disease recurrence
vs. no recurrence. p<0.05 was accepted as statistically signif-
icant. Microsoft Office Excel and SPSS Statistics 17.0 were
used for the calculations. The study was approved by the Ethics
Committee of Collegium Medicum, Jagiellonian University.
Results
A total of 48 patients were deemed eligible for the study, with
33 women who underwent electroablation (group characteris-
tics, Table 1) and 15 subjects who received CO2 laser ablation
(group characteristics, Table 2). Out of the 48 patients who
underwent surgery, five (10.42 %) conceived postoperatively
and were excluded from further analysis. Three (6.25 %)
women withdrew from the study without stating the cause.
At the 3-month checkup, the electroablation and laser ablation
groups comprised 25 (75 %) and 15 (100 %) subjects, respec-
tively. Eventually, the 6-month checkup included 34 (71 %)
patients, 20 (60 %) after electroablation and 14 (93 %) after
CO2 laser ablation. One (2.9 %) woman conceived and five
(14.7 %) resigned from the 6-month checkup.
The statistical analyses generated diversified results. In the
CO2 laser group, the 3-month checkup revealed statistically
significant pain relief only during sexual intercourse (p=
0.035). Pain threshold increased in one (6.67 %), decreased
in nine (60 %), and remained on the same level in five
(33.3 %) patients. In the electroablation group, the 3-month
checkup revealed statistically significant pain relief during
menstruation (p=0.01), urination (p=0.037), and sexual inter-
course (p=0.008). Dysuria decreased from seven to four
points in 7 (28 %), remained on the same level in 16 (64 %),
and increased in 2 (8 %) patients, whereas 12 (50 %) subjects
reported complete resolution of pain symptoms.
The 6-month checkup revealed further changes. In the CO2
laser group, dysmenorrhea significantly subsided (p=0.025), but
dyschezia intensified (p=0.018). Fifteen (100 %) patients pre-
sented no dyschezia complaints before the surgery, but after
6 months, seven (50 %) patients reported pain of mild intensity.
Interestingly, after the initial improvement observed at the 3-
month checkup, the 6-month checkup revealed significantly
intensified dyspareunia (p=0.016). Mean values increased from
3.75 to 9.38 (Fig. 2). In the electroablation group, pain related to
menstruation continued to decrease (p=0.004) (Fig. 1). Seven-
teen (50%) patients reported dysmenorrhea at the level of greater
than or equal to seven points before the surgery, but four and
three points at the 3- and 6-month checkup, respectively. How-
ever, dyspareunia intensified significantly (p=0.032) in that
group. Seventeen (50 %) patients reported dyspareunia at the
level of greater than or equal to two points before the surgery, but
greater than or equal to ten points at the 6-month checkup.
Table 2 Patient characteristics: CO2 laser ablation group
No. of patients (n=15) Mean Median Min. value Max. value
Age 30.17 31 22 39
BMI 20.97 17.75 20.89 24.65
Dysmenorrhea 6.27 7.00 0 10
Dyschezia 0.93 0.0 0 7
Dysuria 1.87 0.0 0 10
PPS 3.6 2.82 0 8
Dyspareunia 3.87 4.0 0 7
Fig. 1 Changes in pain
complaints before/during
menstruation (electroablation vs.
CO2 laser ablation), expressed in
points, before the operation, 3 and
6 months after the surgery
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No statistically significant changes in terms of PPS
(p>0.05) were observed in either of the investigated groups.
The frequency of the use of painkillers and antispasmodic
drugs was also analyzed in both groups. NSAIDs (ketonal,
paracetamol) and antispasmodic drugs (No-Spa) were most
often used. Statistical analysis was carried out for both of these
groups of drugs, and statistically significant decrease in the
use of NSAIDs was noted in both study groups (p=0.008 for
electroablation and p=0.031 for laser ablation), but not sooner
than 6 months postoperatively. The frequency of postopera-
tive use of antispasmodic drugs was comparable to preopera-
tive values (p>0.05).
Owing to the diversified results from both study groups, a
relation between the investigated types of pain and disease
recurrence on transvaginal ultrasound (n=7) was investigated.
Recurrence was noted only in the laser ablation group. A
statistically significant correlation (p=0.02) was found be-
tween intensified dyschezia and disease recurrence at the 6-
month checkup (Table 3) in that group of patients.
No correlations between changes in pain intensity and dis-
ease recurrence on ultrasound within the lesser pelvis (p>0.05)
with regard to the remaining types of pain were found.
Discussion
Pathogenesis of pain in endometriosis remains to be a complex
issue. Regardless of various theories, for example histologic
comorbidity of endometriotic foci and the ends of nerve fibers
[19], changes in TNF gene expression [18], smooth muscle
hyperreflexia and hyperalgesia of interstitium of endometriotic
lesions [20], and excessive innervation of endometrioid ovarian
cysts [21], there is no consensus regarding the pathogenesis of
pain complaints and their diversification. Abdominal
(nociceptive) pain, caused among others by chronic inflamma-
tion and endometrial infiltration into the healthy tissue, is the
main component of endometriosis-related pain, while
nonnociceptive pain (hyperalgesia, psychogenic factors) is of
less significance. Due to the multifactorial nature of pain path-
ogenesis in endometriosis, the “gold standard” is yet to be
established. Thus, the search for optimal patient management,
mostly based on prospective studies, continues. Apart from
surgical removal of the endometriotic lesions, pharmacotherapy
(hormonal contraceptives, gonadotropin agonists) remains to
be the most commonly used alternative method of pain man-
agement, whereas vagus nerve stimulation [22], diet therapy, or
alternative medicine [23] are less popular.
Our investigation generated diversified findings. It seems
that both CO2 laser ablation and electroablation result in relief
of pain complaints before and during menstruation. Although
it is not a disease-specific symptom, dysmenorrhea is a com-
mon complaint among the affected women. Fauconnier et al.
[24] mentioned it in their study, while Hsu et al. [9] suggested
a lack of correlation between pain complaints and location of
endometriosis. Significant decrease in mean pain intensity
and, more importantly, a tendency to further drop after
6 months since the surgery allow to draw optimistic conclu-
sions about the therapeutic effect of both procedures [25]
(Fig. 1). Our results are consistent with the findings of a
randomized prospective study by Sutton et al. [26] and
Jacobson [27] review, with regard to laser ablation.
Similar results have been reported by Radosa et al., who
investigated the effectiveness of electroablation [28], in their
retrospective study over the course of 2 years, and also by
Table 3 Analysis of correlations between pain intensity during sexual intercourse and disease recurrence on ultrasound
Type of pain Usg_recidiv_6 m No. of patients Mean Median Standard deviation Min. value Max. value p value
Defec_pain_6-m laser 0 7 1.00 0.00 1.732 0 4 0.020
1 7 3.86 5.00 2.410 0 6
Fig. 2 Changes in pain
complaints during sexual
intercourse (electroablation vs.
laser ablation), expressed in
points, before the operation, 3 and
6 months after the surgery
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Roman [29] in prospective study of the effects of electrosur-
gical excision.
Also, it is noteworthy that the use of NSAIDs, associated
mostly with dysmenorrhea-related pain, was also statistically
significantly decreased (p<0.08 after 6 months).
Regardless, changes in the intensity of the remaining types
of pain do not allow for unambiguous assessment of the pos-
itive effects of laparoscopic treatment. Both CO2 laser ablation
and electroablation resulted in intensified dyspareunia 6months
postoperatively (Fig. 2) and, especially in the former group,
significantly increased dyschezia. Intensified pain complaints
in these cases might have been the result of the surgical tech-
nique of removing endometriotic lesions from the areas of the
Douglas pouch and uterosacral ligaments, as both of these
locations are associated with these two types of pain [30, 31].
Previous surgical techniques of removing DIE from the area of
uterosacral ligaments deemed to be positive therapeutic results
in terms of subsiding dyspareunia and dysmenorrhea, but they
also increased the number of grave urologic complications due
to nerve damage around the bladder and consequently resulted
in the necessity of self-catheterization in some patients [32, 33].
The precision of CO2 laser, believed to be the essential factor
for preservation of the ovarian reserve in the treatment of
ovarian endometriosis, may have a less beneficial therapeutic
effect in DIE therapy of the Douglas pouch and promotes
earlier recurrence of endometriosis and, consequently, pain
complaints, especially dyspareunia [34, 35]. Meuleman et al.
[36] obtained good results of DIE treatment with the use of CO2
laser, but the study included patients with DIE of the
rectosigmoid area and management consisting of segmental
colon resection with the additional use of CO2 laser.
Evaluation of partial therapeutic effect ought to take into
account hyperalgesia of the nerve endings of tissues theoret-
ically neighboring DIE lesions [37], which in case of
electroablation and laser ablation, probably are less damaged
than by the radical surgical approach. As a result, disease
recurrence takes place faster than after the classical approach,
i.e., excision of the endometriotic lesions with a margin of
healthy tissue. Such an explanation is consistent with the
results of the abovementioned study by Meuleman et al. Par-
adoxically, the precision of CO2 laser, believed to be its
advantage in the treatment of ovarian endometriosis, might
not correspond to the long-term therapeutic effect in pain
management of extra ovarian endometriosis, i.e., DIE.
Conclusions
Pain relief in patients after laparoscopic CO2 laser ablation
and electroablation is short-term and incomplete. Precision of
the CO2 laser and relatively limited tissue damage during
electroablation seem to be irrelevant when it comes to their
practical application in treating pain related to extra ovarian
endometriosis. Owing to a short postoperative observation
period, our results should be regarded as a preliminary eval-
uation of treatment efficacy for pain complaints [38]. Further
prospective analysis is necessary, and additionally, long-term
hormonal therapy as adjuvant to laparoscopic treatment ought
to be considered [39].
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